Efficacy and safety of probiotics in preterm infants

Journal of Neonatal-Perinatal Medicine

Volumn 6, Issue 1, 2013, Pages 1-9

  Alfaleh, K ^a   Anabrees, J ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Sulaiman Al Habib Medical Group ^*  (Saudi Arabia)

Author keywords

NEC; neonatal sepsis; preterm; Probiotics

Indexed keywords

PROBIOTIC AGENT;

DRUG EFFICACY; DRUG SAFETY; ENTERIC FEEDING; HUMAN; MORTALITY; NECROTIZING ENTEROCOLITIS; NEWBORN SEPSIS; PREMATURITY; PRIORITY JOURNAL; REVIEW;

NEC; NEONATAL SEPSIS; PRETERM; PROBIOTICS;

DIETARY SUPPLEMENTS; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFUSIONS, PARENTERAL; MALE; META-ANALYSIS AS TOPIC; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS; TREATMENT OUTCOME;

EID: 84876986460     PISSN: 19345798     EISSN: 18784429     Source Type: Journal    
DOI: 10.3233/NPM-1363712     Document Type: Review

References (54)

1. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989;66(5):365-78.
2. Metchnikoff E. Lactic acid as inhibiting intestinal putrefaction In: The prolongation of life: Optimistic studies. W. Heinemann, London 1907:161-83.
3. Tissier H.Traitement des infections intestinalespar lam'ethode de la florebact'erienne de l'intestin.CRSoc Biol 1906;60:359- 61.
4. Food and Agriculture Organization/World Health Organization (FAO/WHO). Joint FAO/WHO Working Group Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada 2002.
5. Lee JS, Polin RA. Treatment and prevention of necrotizing enterocolitis. Semin Neonatol 2003;8:449-59.
6. Kafetzis DA, Skevaki C, Costalos C. Neonatal necrotizing enterocolitis:Anoverview. Curr Opin Infect Dis 2003;16:349- 55.
7. Kosloske AM. Epidemiology of necrotizing enterocolitis. Acta Paediatr 1994;396:2-7.
8. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1-7.
9. Neu J. Necrotizing enterocolitis: The search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am 1996;43:409-32.
10. Kosloske AM. Pathogenesis and prevention of necrotizing enterocolitis:Ahypothesis based on personal observation and a review of the literature. Pediatrics 1984;74:1086-92.
11. La Gamma EF, Browne LE. Feeding practices for infants weighing less than 1500 G at birth and the pathogenesis of necrotizing enterocolitis. Clin Perinatol 1994;21:271-306.
12. Kosloske AM. A unifying hypothesis for pathogenesis and prevention of necrotizing enterocolitis. J Pediatr 1990;117:S68-S74.
13. Musemeche CA, Kosloske AM, Bartow SA, Umland ET. Comparative effects of ischemia, bacteria, and substrate on the pathogenesis of intestinal necrosis. J Pediatr Surg 1986;21:536-8.
14. GoldmannDA, Leclair J, Macone A. Bacterial colonization of neonates admitted to an intensive care environment. J Pediatr 1978;93:288-93.
15. Gewolb IH, Schwalbe RS, Taciak VL, Harrison TS, Panigrahi P. Stool microflora in extremely lowbirthweight infants. Arch Dis Child Fetal Neonatal Ed 1999;80:F167-F73.
16. Holman RC, Stoll BJ, Clarke MJ, Glass RI. The epidemiology of necrotizing enterocolitis infant mortality in the United States. Am J Public Health 1997;87:2026-31.
17. Caplan MS, Jilling T. New concepts in necrotizing enterocolitis. Curr Opin Pediatr 2001;13:111-5.
18. Ricketts RR. Surgical treatment of necrotizing enterocolitis and the short bowel syndrome. Clin Perinatol 1994;21:365- 87.
19. Bisquera JA, Cooper TR, Berseth CL. Impact of necrotizing enterocolitis on length of stay and hospital charges in very low birth weight infants. Pediatrics 2002;109:423-8.
20. Stoll BJ, Hansen NI, ms-Chapman I, Fanaroff AA, Hintz SR, Vohr B, Higgins RD. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357-65.
21. Millar M, Wilks M, Costeloe K. Probiotics for preterm infants? Arch Dis Child Fetal Neonatal Ed 2003;88:F354-F8.
22. Orrhage K, Nord CE. Factors controlling the bacterial colonization of the intestine in breastfed infants. Acta Paediatr Suppl 1999;88:47-57.
23. Mattar AF, Drongowski RA, Coran AG, Harmon CM. Effect of probiotics on enterocyte bacterial translocation in vitro. Pediatr Surg Int 2001;17:265-8.
24. Reid G, Howard J, Gan BS. Can bacterial interference prevent infection? Trends Microbiol 2001;9:424-8.
25. Duffy LC. Interactions mediating bacterial translocation in the immature intestine. J Nutr 2000;130:432S-36S
26. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM.Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 1994;10:55-63.
27. AlFaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011;16(3):CD005496.
28. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al. Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:63-71.
29. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(2 Pt 1):285-91.
30. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing earlyonset sepsis in very-low-birth-weight infants.NewEngl JMed 2002;347:240-7.
31. RichardV,Van derAuwera AP, Snoeck R, Daneau D, Meunier F. Nosocomial bacteremia caused by Bacillus species. Eur J Clin Microbiol Infect Dis 1988;7:783-5.
32. Husni RN, Gordon SM, Washington JA, et al. Lactobacillus bacteremia and endocarditis: Review of 45 cases. Clin Infect Dis 1997;25:1048-55.
33. Piarroux R, Millon L, Bardonnet K, et al. Are live Saccharomyces yeasts harmful to patients? Lancet 1999;353: 1851-2.
34. Rautio M, Jousimies-Somer H, Kauma H, et al. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosusstrain GG. Clin Infect Dis 1999;28:1159- 60.
35. Ishibashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr 2001;73:465S-70S.
36. Sharpe ME, Hill LR, Lapage SP. Pathogenic lactobacilli. J Med Microbiol 1973;6:281-6.
37. Bayer AS, Chow AW, Betts D, et al. Lactobacillemia: Report of nine cases. Important clinical and therapeutic considerations. Am J Med 1978;64:808-13.
38. Broughton RA, Gruber WC, Haffar AA, et al. Neonatal meningitis due to Lactobacillus. Pediatr Infect Dis 1983;2:382-4.
39. Kalima P, Masterton RG, Roddie PH, et al. Lactobacillus rhamnosus infection in a child following bone marrow transplant. J Infect 1996;32:165-7.
40. Brook I. Isolation of non-sporing anaerobic rods from infections in children. J Med Microbiol 1996;45:21-6.
41. Thompson C, McCarter Y, Krause PJ, et al. Lactobacillus acidophilus sepsis in a neonate. J Perinatol 2001;21:258-60.
42. AFSSA (AgenceFrançaise de Śecurit́eSanitaire des Aliments). Alimentation Infantile et Modification de la Flore Intestinale (working document) 2003.
43. Scientific Committee on Food. European Commission. Health and Consumer Protection Directorate-General. Report of the Scientific Committee on Food on the Revision of Essential Requirements of Infant Formulas and Follow-up Formulas 2003.
44. Mackay AD, Taylor MB, Kibbler CC, et al. Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 1999;5:290-2.
45. Hennequin C, Kauffmann-Lacroix C, Jobert A, et al. Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis 2000;19:16-20.
46. Spinosa MR, Wallet F, Courcol RJ, et al. The trouble in tracing opportunistic pathogens: Cholangitis due to Bacillus in a French hospital caused by a strain related to an Italian probiotic? Microb Ecol Health Dis 2000;12:99-101.
47. Oggioni MR, Pozzi G, Balensin PE, et al. Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J Clin Microbiol 1998;36:325-6.
48. Salminen MK, Tynkkynen S, Rautelin H, et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002;35:1155-60.
49. Borritello SP, Hammes WP, HolzapfelW, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003;36:775-80.
50. Manzoni P, Lista G, Gallo E, et al. Routine Lactobacillus rhamnosus GG administration in VLBW infants: A retrospective, 6-year cohort study. Early Hum Dev 2011;87(Supp 1):S35-S8.
51. Marteau P. Safety aspects of probiotic products. Scand J Nutr 2001;45:22-4.
52. ESPGAN. J Pediatr Gastroenterol Nutr 2004;38(4).
53. Soll R. Probiotics: AreWe Ready for Routine Use? Pediatrics 2010;125:1071-2. PMID:20421256
54. Tarnow-Mordi W, Wilkinson D, Trivedi A, et al. Probiotics reduce all-cause mortality and necrotizing enterocolitis: It is time to change practice. Pediatrics 2010;125:1068-70. PMID:2040393